# 40-Question Diagnostic Score Summary

**Company:** [Company Name]
**Date:** [YYYY-MM-DD]
**Evaluator:** [Name/Organization]
**Project Stage:** [From Step 0]

---

## EXECUTIVE SUMMARY

[Paragraph 1: 2-3 sentences on overall assessment across the four dimensions - Team, Technology, Management, Commercial. What is the overall readiness level? What stands out most - strength or concern?]

[Paragraph 2: 2-3 sentences on key strengths. What are the 1-2 strongest dimensions or capabilities? What gives this venture its competitive advantage or foundation for success?]

[Paragraph 3: 2-3 sentences on critical gaps and recommendation. What are the 1-2 most critical gaps or risks? What is the recommended next step - proceed, conditional proceed, request information, or non-viable?]

---

## DIMENSIONAL SCORES

| Dimension | Score | Status | Key Finding (One-line) |
|-----------|-------|--------|------------------------|
| **Team** | ___.___ / 5.0 | [STRONG/ADEQUATE/CONCERN/CRITICAL] | [One-line key finding about team] |
| **Technology** | ___.___ / 5.0 | [STRONG/ADEQUATE/CONCERN/CRITICAL] | [One-line key finding about technology] |
| **Management** | ___.___ / 5.0 | [STRONG/ADEQUATE/CONCERN/CRITICAL] | [One-line key finding about management] |
| **Commercial** | ___.___ / 5.0 | [STRONG/ADEQUATE/CONCERN/CRITICAL] | [One-line key finding about commercial] |

**Overall Assessment:** [STRONG / ADEQUATE / CONCERNS / CRITICAL GAPS]

**Status Key:**
- **STRONG**: Score â‰¥ 4.0 - Exceeds expectations for stage
- **ADEQUATE**: Score 3.0-3.9 - Meets expectations for stage
- **CONCERN**: Score 2.0-2.9 - Below expectations, gaps need addressing
- **CRITICAL**: Score < 2.0 - Major deficiencies, immediate action required

---

## TOP 5 STRENGTHS

1. **[Question ID]** (Score [X]): [Strength description - what makes this strong and why it matters]
2. **[Question ID]** (Score [X]): [Strength description - what makes this strong and why it matters]
3. **[Question ID]** (Score [X]): [Strength description - what makes this strong and why it matters]
4. **[Question ID]** (Score [X]): [Strength description - what makes this strong and why it matters]
5. **[Question ID]** (Score [X]): [Strength description - what makes this strong and why it matters]

---

## TOP 5 GAPS/CONCERNS

1. **[Question ID]** (Score [X]): [Gap description and why it matters - impact on viability or timeline]
2. **[Question ID]** (Score [X]): [Gap description and why it matters - impact on viability or timeline]
3. **[Question ID]** (Score [X]): [Gap description and why it matters - impact on viability or timeline]
4. **[Question ID]** (Score [X]): [Gap description and why it matters - impact on viability or timeline]
5. **[Question ID]** (Score [X]): [Gap description and why it matters - impact on viability or timeline]

---

## RED FLAGS

**Total Red Flags:** [___]

**Critical Red Flags (if any):**
- [Red flag 1 - dimension and specific issue]
- [Red flag 2 - dimension and specific issue]
- [Red flag 3 - dimension and specific issue]

**If no red flags:** No critical red flags identified. [Note any concerns that aren't quite red flags but worth monitoring]

**Risk Level:** [LOW / MODERATE / HIGH / CRITICAL]

**Risk Assessment:**
- **HIGH/CRITICAL**: Multiple red flags across dimensions, fundamental viability questions
- **MODERATE**: 1-2 red flags or several Score 2 items, addressable but concerning
- **LOW**: No red flags, gaps are typical for current stage

---

## STRATEGIC RECOMMENDATIONS

### Immediate Actions Required (0-30 days)

1. **[Action]** - [Why critical and what outcome needed] - **Priority:** [HIGH/MEDIUM]
2. **[Action]** - [Why critical and what outcome needed] - **Priority:** [HIGH/MEDIUM]
3. **[Action]** - [Why critical and what outcome needed] - **Priority:** [HIGH/MEDIUM]

### Medium-term Priorities (1-6 months)

1. **[Action]** - [Why important and what outcome needed] - **Timeline:** [Specific timeframe]
2. **[Action]** - [Why important and what outcome needed] - **Timeline:** [Specific timeframe]
3. **[Action]** - [Why important and what outcome needed] - **Timeline:** [Specific timeframe]

### Questions for Founders (Top 3 Priority)

1. **[Question about INSUFFICIENT DATA or critical gap]** - [Why this information is needed]
2. **[Question about INSUFFICIENT DATA or critical gap]** - [Why this information is needed]
3. **[Question about INSUFFICIENT DATA or critical gap]** - [Why this information is needed]

---

## STAGE APPROPRIATENESS ASSESSMENT

**Current Stage:** [Idea / Prototype / Pilot / Early Commercialization / Growth]

**Stage Expectations vs. Reality:**

| Dimension | Expected for Stage | Actual Score | Assessment |
|-----------|---------------------|--------------|------------|
| Team | [Range] | [Score] | [Exceeds / Meets / Below / Significantly Below] |
| Technology | [Range] | [Score] | [Exceeds / Meets / Below / Significantly Below] |
| Management | [Range] | [Score] | [Exceeds / Meets / Below / Significantly Below] |
| Commercial | [Range] | [Score] | [Exceeds / Meets / Below / Significantly Below] |

**Stage Expectations Guide:**
- **Idea Stage:** Team 2.5-3.5, Tech 2.0-3.0, Mgmt 2.0-2.5, Commercial 1.5-2.5
- **Prototype Stage:** Team 3.0-4.0, Tech 2.5-3.5, Mgmt 2.5-3.0, Commercial 2.0-3.0
- **Pilot Stage:** Team 3.5-4.5, Tech 3.0-4.0, Mgmt 3.0-3.5, Commercial 2.5-3.5
- **Early Commercialization:** Team 4.0+, Tech 3.5+, Mgmt 3.5+, Commercial 3.0+
- **Growth:** Team 4.5+, Tech 4.0+, Mgmt 4.0+, Commercial 4.0+

**Appropriateness Assessment:**

[2-3 sentences: Are the scores appropriate for the stated stage? Is the venture punching above its weight in any dimension? Are there stage-inappropriate gaps (e.g., Growth stage with no customer validation)?]

---

## RECOMMENDATION

**Overall Assessment:** [Select one]

- [ ] **PROCEED TO STEP 3** - Strong or adequate across dimensions, ready for Market Maturity Assessment
- [ ] **CONDITIONAL PROCEED** - Proceed to Step 3 but note specific gaps that must be addressed for investment consideration
- [ ] **REQUEST ADDITIONAL INFO** - Too many INSUFFICIENT DATA items, need more information before meaningful assessment
- [ ] **SIGNIFICANT CONCERNS** - Multiple critical gaps or red flags, recommend validation sprint before investment consideration
- [ ] **NON-VIABLE** - Critical gaps across multiple dimensions suggest fundamental issues, pivot or extensive validation needed

**Selected Recommendation:** [Name]

**Justification (2-3 sentences):**

[Explain the recommendation based on scores, gaps, red flags, and stage appropriateness. Be specific about what drove this decision. If conditional, specify the conditions. If requesting information, specify what's needed.]

---

## NEXT STEPS

**Immediate Next Actions:**

1. **[Action 1]** - [Who should do this and by when]
2. **[Action 2]** - [Who should do this and by when]
3. **[Action 3]** - [Who should do this and by when]

**If Proceeding to Step 3:**
- Review Market Maturity Assessment requirements (29 questions)
- Prepare evidence for five dimensions: Legitimacy, Desirability, Acceptability, Feasibility, Viability
- Estimated time: 45-60 minutes
- Expected to surface additional evidence gaps

**If Requesting Information:**
- Send "Questions for Founders" list to startup team
- Request specific evidence or validation data
- Schedule follow-up meeting if needed
- Target response time: [Specify deadline]

**If Significant Concerns:**
- Discuss findings with venture/investment committee
- Consider structured validation sprint: [Specify what to validate]
- Re-assess after validation work complete
- Timeline for re-assessment: [Specify]

---

## KEY INSIGHTS FOR DISCUSSION

**Strengths to Leverage:**
1. [Insight about a key strength and how to leverage it]
2. [Insight about a key strength and how to leverage it]

**Risks to Mitigate:**
1. [Insight about a key risk and how to mitigate it]
2. [Insight about a key risk and how to mitigate it]

**Strategic Questions for Committee:**
1. [Question for evaluation committee to discuss]
2. [Question for evaluation committee to discuss]
3. [Question for evaluation committee to discuss]

---

## COMPARISON TO PORTFOLIO/COHORT

**If applicable - compare to similar ventures:**

| Metric | This Venture | Portfolio Average | Assessment |
|--------|--------------|-------------------|------------|
| Team Score | [___] | [___] | [Above/Below/Comparable] |
| Technology Score | [___] | [___] | [Above/Below/Comparable] |
| Management Score | [___] | [___] | [Above/Below/Comparable] |
| Commercial Score | [___] | [___] | [Above/Below/Comparable] |
| Overall Score | [___] | [___] | [Above/Below/Comparable] |

**Comparative Insight:**

[1-2 sentences: How does this venture compare to others at similar stage? What percentile would you place them in based on these scores?]

---

## FILE OUTPUTS

**Save as:**
- Markdown: `[CompanyName]_[YYYY-MM-DD]_02_Diagnostic_Summary.md`
- DOCX: `[CompanyName]_[YYYY-MM-DD]_02_Diagnostic_Summary.docx`

**Example:**
- `HealthTech_2025-01-15_02_Diagnostic_Summary.md`
- `HealthTech_2025-01-15_02_Diagnostic_Summary.docx`

---

## DISTRIBUTION

**Internal Distribution:**
- [ ] Investment Committee
- [ ] Program Manager
- [ ] Mentor/Advisor Network
- [ ] Portfolio Management Team

**Founder Distribution:**
- [ ] Share full Score Summary
- [ ] Share selective findings only
- [ ] Schedule discussion meeting first
- [ ] Do not share (internal use only)

---

## FOLLOW-UP TRACKING

**Follow-up Date:** [YYYY-MM-DD]

**Items to Track:**
1. [ ] Response to "Questions for Founders" received
2. [ ] Additional validation completed (if requested)
3. [ ] Step 3 Market Maturity Assessment scheduled/completed
4. [ ] Committee decision made
5. [ ] Founders notified of outcome

**Responsible Party:** [Name]

---

## DOCUMENT CONTROL

**Document Status:** [Draft / Final / Revised]
**Version:** [1.0]
**Last Updated:** [YYYY-MM-DD]
**Related Documents:**
- Executive Brief: `[Filename]`
- Assessment Results: `[CompanyName]_[Date]_02_Diagnostic_Results.md`
- Next Assessment: Step 3 Market Maturity (if proceeding)

---

**Template Version:** 1.0 - Step 2 Score Summary (Document 2 of 2)
**Last Updated:** 2025-01-15
**Compatible with:** VIANEO 8-Step Evaluation System
**Purpose:** Executive-level summary for decision-makers
